Literature DB >> 8575471

Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbs.

W C Barker1, M P Andrich, H R Alexander, D L Fraker.   

Abstract

Regional isolated perfusion using tumor necrosis factor (TNF) shows significant promise for treatment of cancer which is limited to limbs or organs. The high toxicity of TNF requires very sensitive real time monitoring of leakage in order to avoid serious patient complications. Human serum albumin labeled with iodine-131 is used with an externally mounted and collimated NaI(Tl) detector to track the leakage of blood from the isolated perfusion blood circuit into the general systemic vascular space. Blood activity levels measured using the monitor demonstrated a very good correlation with blood serum samples taken concurrently with external monitoring. External monitoring can reduce the risks of perfusion leakage intraoperatively with the precision necessary to safely perform isolated perfusion using TNF.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8575471     DOI: 10.1007/bf00801607

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  16 in total

1.  Treatment of malignant tumors of the extremities by perfusion with chemotherapeutic agents.

Authors:  E T KREMENTZ; O CREECH; R F RYAN; J WICKSTROM
Journal:  J Bone Joint Surg Am       Date:  1959-09       Impact factor: 5.284

2.  Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit.

Authors:  O CREECH; E T KREMENTZ; R F RYAN; J N WINBLAD
Journal:  Ann Surg       Date:  1958-10       Impact factor: 12.969

3.  The use of a hand-held gamma detector improves the safety of isolated limb perfusion.

Authors:  A Sardi; J P Minton; C Mojzisik; C A Nieroda; P J Ferrara; G H Hinkle; M O Thurston; E W Martin
Journal:  J Surg Oncol       Date:  1989-07       Impact factor: 3.454

4.  Effects of intra-arterial administration of nitrogen mustard.

Authors:  H R BIERMAN; R L BYRON; E R MILLER; M B SHIMKIN
Journal:  Am J Med       Date:  1950-04       Impact factor: 4.965

5.  High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.

Authors:  D Lienard; P Ewalenko; J J Delmotte; N Renard; F J Lejeune
Journal:  J Clin Oncol       Date:  1992-01       Impact factor: 44.544

6.  Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future.

Authors:  B B Kroon
Journal:  Eur J Surg Oncol       Date:  1988-04       Impact factor: 4.424

7.  Hyperthermic perfusion with chemotherapy for cancers of the extremities.

Authors:  J S Stehlin
Journal:  Surg Gynecol Obstet       Date:  1969-08

8.  Blood leakage and melphalan leakage from the perfusion circuit during regional hyperthermic perfusion for malignant melanoma.

Authors:  L Hafström; A Hugander; P E Jönsson; H Westling; H Ehrsson
Journal:  Cancer Treat Rep       Date:  1984-06

9.  Venous bypass in clinical liver transplantation.

Authors:  B W Shaw; D J Martin; J M Marquez; Y G Kang; A C Bugbee; S Iwatsuki; B P Griffith; R L Hardesty; H T Bahnson; T E Starzl
Journal:  Ann Surg       Date:  1984-10       Impact factor: 12.969

10.  Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan.

Authors:  A K Thom; H R Alexander; M P Andrich; W C Barker; S A Rosenberg; D L Fraker
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

View more
  3 in total

1.  Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.

Authors:  Ilan Ben-Shabat; Christoffer Hansson; Malin Sternby Eilard; Christian Cahlin; Magnus Rizell; Per Lindnér; Jan Mattsson; Roger Olofsson Bagge
Journal:  J Vis Exp       Date:  2015-01-25       Impact factor: 1.355

Review 2.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

3.  Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion.

Authors:  Elizabeth D Feldman; Peter C Wu; Tatiana Beresneva; Cynthia Helsabeck; Montessa Rodriguez; David L Bartlett; Steven K Libutti; James F Pingpank; H Richard Alexander
Journal:  J Gastrointest Surg       Date:  2004-02       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.